Westford, USA, Nov. 29, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the blood culture tests market size will attain a value of USD 17.50 billion by 2031, with a CAGR of 12.3% over the forecast period (2024-2031). Rising incidence of bloodstream infections and a growing number of surgical procedures performed around the world are expected to bolster the blood culture tests market growth over the coming years. Spreading awareness regarding the benefits of blood culture tests and use of advanced technologies are expected to generate new opportunities in the future.
Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/blood-culture-tests-market
Browse in-depth TOC on “Blood Culture Tests Market”
- Pages – 198
- Tables – 144
- Figures – 74
Blood Culture Tests Market Overview:
| Report Coverage | Details |
| Market Revenue in 2023 | $ 6.92 Billion |
| Estimated Value by 2031 | $ 17.50 Billion |
| Growth Rate | Poised to grow at a CAGR of 12.3% |
| Forecast Period | 2024–2031 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Method, Product, Technology, Application, End-Use, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the world |
| Report Highlights | Rapidly increasing surgical procedure volumes |
| Key Market Opportunities | Use of advanced technologies such as MALDI-TOF mass spectrometry |
| Key Market Drivers | Growing prevalence of bloodstream infections |
Blood Culture Tests Market Segmental Analysis
Global Blood Culture Tests Market is segmented based on the Method, Product, Technology, Application, End-Use, and Region.
Based on Product, the market is segmented into Conventional/Manual Methods, Automated Methods.
Based on Product, the market is segmented into Consumables, Instruments, Software and Services.
Based on Technology, the market is segmented into Culture-based Technology, Molecular Technology, Proteomics Technology.
Based on Application, the market is segmented into Bacteremia, Fungemia, Mycobacterial Detection.
Based on End Use, the market is segmented into Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Established Dependability of Conventional Processes Makes them a Popular Choice
Conventional blood culture tests involved incubation of blood samples in a culture medium to identify microbial development. High dependability and reliability of conventional blood culture tests allow them to hold a dominant blood culture tests market share. These tests are expected to lose some market share to automated tests in the long run.
Rising Prevalence of Mycobacterial Diseases Makes it an Opportune Segment
Growing incidence of mycobacterial diseases such as tuberculosis around the world is projected to primarily bolster the demand for blood culture tests in mycobacterial infection applications going forward. High emphasis on tuberculosis management and efforts to improve diagnosis and management of mycobacterial infections are also creating new opportunities for market players.
For a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/blood-culture-tests-market
Growing Healthcare Expenditure is Helping North America Maintain its Global Dominance
Growing surgical procedure volumes, high incidence of infectious diseases, and rising spending on healthcare are slated to bolster blood culture test demand in North America. The presence of a strong regulatory framework to promote proactive disease diagnosis and management also helps boost the adoption of blood culture tests in this region. Canada and the United States remain the leading markets in the North American region.
Blood Culture Tests Market Insights:
Drivers
- Rising incidence of bloodstream infections
- Increasing surgical procedure volumes around the world
- Expanding geriatric population base
Restraints
- Difficulty in the interpretation of blood culture results
- Time-consuming nature of conventional blood culture tests
- Dearth of skilled laboratory professionals
Prominent Players in Blood Culture Tests Market
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Eli Lilly and Company (U.S.)
- Merck & Co., Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Siemens Healthcare Private Limited (Germany)
- Danaher Corporation (U.S.)
- ZEPTOMETRIX (U.S.)
- CytoTest Inc. (U.S.)
- Devyser (Sweden)
- Bruker (U.S.)
- BIOMÉRIEUX (France)
- Bayer AG (Germany)
- BD (U.S.)
Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/positron-emission-tomography-market
Key Questions Answered in Blood Culture Tests Market Report
- What drives the demand for blood culture tests?
- Which region leads the global blood culture tests market forecast?
- What restraints are expected to trouble companies?
- Which segment brings in the most revenue as per this blood culture tests market analysis?
This report provides the following insights:
Analysis of key drivers (rising incidence of bloodstream infections, growing senescent population), restraints (absence of skilled workforce, difficulty in interpretation of blood culture results), and opportunities (use of advanced technologies such as MALDI-TOF mass spectrometry) influencing the growth of blood culture tests market.
- Market Penetration: All-inclusive analysis of product portfolio of different market players and status of new product launches.
- Product Development/Innovation: Elaborate assessment of R&D activities, new product development, and upcoming trends of the blood culture tests market.
- Market Development: Detailed analysis of potential regions where the market has potential to grow.
- Market Diversification: Comprehensive assessment of new product launches, recent developments, and emerging regional markets.
- Competitive Landscape: Detailed analysis of growth strategies, revenue analysis, and product innovation by new and established market players.
To read the full report, please visit: https://www.skyquestt.com/report/blood-culture-tests-market
Related Reports:
Pyrogen Testing Market Set to Grow at 13.4% CAGR Through 2031
Medical Document Management Systems Market Set to Grow at 11.9% CAGR Through 2031
Blood Culture Tests Market Set to Grow at 12.3% CAGR Through 2031
Behavioral Rehabilitation Market Set to Grow at 6.9% CAGR Through 2031
Positron Emission Tomography Market Set to Grow at 6.61% CAGR Through 2031
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj Singh
Skyquest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4717.50
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/
